ADDYI is the “Viagra for women” –or so they say. The FDA recently approved Addyi (Flibanserin) for treatment of hypoactive sexual desire disorder in premenopausal women. It is estimated that 40-50 percent of women have some sort of sexual dysfunction and this is the first medication the FDA has approved for this type of issue.
Several patients have asked me about a recent article in the Wall Street Journal concerning the use of multiple ultrasounds during routine pregnancy without clear medical need. The article suggests that many expectant mothers have too many ultrasounds, some even receiving up to a dozen in one pregnancy. The article states that some experts recommend